Terumo Interventional Systems (TIS) is a Division of TERUMO group and a market leader in minimally invasive entry site management, lesion access, and interventional technologies. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral endovascular and urological treatments with strategic initiatives in Transracial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy. TIS Division contributes to better treatment outcomes and quality of life for patients, and helps doctors perform at the highest levels of their capabilities. *Posts in our account regarding medical drugs and medical devices are intended for healthcare professionals only. About TERUMO Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. Terumo will further strive to be of value to patients, medical professionals, and society at large.